Institutional Ownership
Myovant Sciences Ltd
CUSIP G637AM102COMMON STOCK-FOQ1 2026
13D / 13G Filings
27
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
100.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
27 filings · latest Mar 10, 2023
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Mar 10, 2023 | Sumitomo Chemical Co., Ltd. | 13D/A | 100.0% | 45.80M | SEC |
| 2 | Mar 6, 2023 | Sumitomo Chemical Co., Ltd. | 13D/A | 51.5% | 50.04M | SEC |
| 3 | Feb 17, 2023 | Alpine Global Management, LLC | 13G | 6.6% | 6.43M | SEC |
| 4 | Feb 14, 2023 | Bb Biotech AG | 13G/A | 6.0% | 5.87M | SEC |
| 5 | Feb 9, 2023 | Janus Henderson Group PLC | 13G/A | 1.2% | 1.18M | SEC |
| 6 | Feb 9, 2023 | Fil Ltd | 13G | 8.9% | — | SEC |
| 7 | Feb 6, 2023 | Wellington Management Group LLP | 13G/A | 0.0% | 7.3K | SEC |
| 8 | Oct 24, 2022 | Sumitomo Chemical Co., Ltd. | 13D/A | 51.7% | 50.04M | SEC |
| 9 | Oct 3, 2022 | Sumitomo Chemical Co., Ltd. | 13D/A | 52.2% | 50.04M | SEC |
| 10 | Feb 11, 2022 | Bb Biotech AG | 13G/A | 6.6% | 6.12M | SEC |
17 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Myovant Sciences Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $27 |